GCTK Stock Summary and Trading Ideas (Glucotrack | :GCTK)

GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

Glucotrack trades on the stock market under the symbol GCTK.

As of November 4, 2026, GCTK stock price was flat at $1.39 with million shares trading.

GCTK has a beta of 2.36, meaning it tends to be more sensitive to market movements. GCTK has a correlation of 0.03 to the broad based SPY ETF.

GCTK has a market cap of $1.65 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, GCTK traded as high as $178,200.00 and as low as $.75.

GCTK has underperformed the market in the last year with a return of -99.3%, while the SPY ETF gained +13.1%. In the last 3 month period, GCTK fell short of the market, returning -88.8%, while SPY returned +1.2%. However, in the most recent 2 weeks GCTK has outperformed the stock market by returning +6.7%, while SPY returned -0.5%.

GCTK support price is $1.19 and resistance is $1.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GCTK shares will trade within this expected range on the day.